An initiative that brings together experts in cardiovascular and immune-mediated inflammatory diseases across 30 centres in the UK.
See Our CentresOur mission is to transform the management of cardiovascular involvement of people with IMIDs through better understanding of inflammation science of cardiovascular disease, enhanced diagnostics and monitoring and precision therapeutics. This will be achieved by establishing a world class patient-centred, dynamic and sustainable, collaborative UK infrastructure in cardio-rheumatology to conduct scalable experimental medicine research and targeted therapeutic trials.
The UK CARDIO-IMID Partnership is the first national network of inter-disciplinary rheumatology and cardiovascular clinicians, clinician scientists and basic scientists that wish to address the unmet needs of people with IMIDs and cardiovascular involvement and thereby improve outcomes of people with IMIDs and the wider population.
We initially developed a UK network of cardiovascular and rheumatology clinicians and researchers from 30 centres across the UK with the support of the National Institute of Health and Care Research (NIHR)-British Heart Foundation (BHF) Cardiovascular . With Medical Research Council and British Heart Foundation (BHF) co-funding awarded in 2023, we have established the UK CARDIO-IMID Partnership.
Working across this national network that reaches all devolved nations, the UK CARDIO-IMID Partnership will strengthen collaborations to support training and education in cardio-rheumatology, sharing of best practice and development and delivery of high-quality biomedical research studies.
We are an inclusive working group and welcome investigators with ideas for collaborative education and research efforts at the intersection of inflammatory and cardiovascular diseases.
In this review article published in Rheumatology, Dr Marta Peverelli and Dr Jason Tarkin from the UK CARDIO-IMID PET-CT team in Cambridge explore several of the most promising emerging PET radionucleotide tracers for imaging vascular inflammation.
Read More
In this case-study, published by the National Institute for Health and Care Research (NIHR), the aims and objectives of the UK CARDIO-IMID Partnership are outlined, and context provided regarding how the Partnership sits within the established infrastructure of the NIHR Biomedical Research Centres and British Heart Foundation Centres of Research Excellence.
Read MoreIn this letter published in Rheumatology, authored by our chief investigator Professor Maya H. Buch and UK CARDIO-IMID Partnership members from Manchester, we present the results of a UK-wide survey of 85 rheumatology clinicians seeking to understand how cardiovascular risk assessment in patients with IMIDs is approached in the hospital setting, and perspectives on cardiovascular imaging.
Read MoreA key aim of the Partnership is to connect leading cardiovascular and immunology researchers and institutions across the UK to generate novel collaborative research projects and increase the profile of CARDIO-IMID in the UK healthcare sector. Our current participating centres can be viewed in the infographic below.
